Keywords: Russia, Pharma public procurement, Tender system, Novartis, Competition

Novartis criticizes system of public procurement tenders in Russia

Article | 28 September 2012

Amid the ever growing competition in the Russian pharmaceutical market, the world's largest pharmaceutical giants are gradually losing ground to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing